1661 - 1670 of 6324 Results
Title
Year
-
OPENTitle: Use of Florbetapir-PET for Imaging β-Amyloid PathologyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 305Issue #: 3Start Page: 275End Page: 275Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2010.2008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7041965Citation Count: 1029
-
OPENTitle: M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 1763End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-018-0033-9Best OA location URL: https://www.nature.com/articles/s41386-018-0033-9.pdfCitation Count: 73
- Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's disease2014OPENTitle: Clinician versus machine: Reliability and responsiveness of motor endpoints in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 590End Page: 595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.022Citation Count: 147
-
OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4). Part II: Challenges in hit-to-leadJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 962End Page: 966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.11.104Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3787871Citation Count: 55
-
OPENTitle: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structuresJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 5Start Page: 795End Page: 808Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2Citation Count: 265
-
OPENTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: http://doi.org/10.1124/mol.108.049551Citation Count: 185
-
OPENTitle: Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography studyJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25929Best OA location URL: https://hdl.handle.net/2027.42/108363Citation Count: 112
-
OPENTitle: Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 PhosphorylationJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 8Start Page: e43580End Page: e43580Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0043580Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0043580&type=printableCitation Count: 38
-
OPENTitle: 4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discoveryJournal Name: Expert Opinion on Drug DiscoveryPublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 337End Page: 341Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1517/17460441.2016.1154529Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1517/17460441.2016.1154529?needAccess=trueCitation Count: 18
-
OPENTitle: Sensitivity to change and prediction of global change for the Alzheimer’s QuestionnaireJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-014-0092-zBest OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-014-0092-zCitation Count: 129